At CROI 2025, researchers from Université de Montréal discuss how fostemsavir could target residual viral fragments and reduce inflammation.
Mehdi Benlarbi
Advertisement
PhD Student at Univsersité de Montréal.
Articles by Mehdi Benlarbi
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Hackensack Meridian Health Joins Phase 3 Trial of Pfizer’s Investigational C difficile Vaccine
2
Initiatives Look to Strengthen Vaccine Policy and Governance in US
3
Lenacapavir and the Future of HIV Prevention: PURPOSE Trials, Long-Acting PrEP, and What Comes Next
4
Infectious Disease Regulatory Watch: June Highlights
5